Improvement in sensitivity with delayed imaging of pulmonary lesions with FDG-PET

Revista Espanola de Medicina Nuclear

Volumn 26, Issue 4, 2007, Pages 196-207

  Nunez R ^a,b   Kalapparambath, A ^a   Varela, J ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Dual time; FDG; PET; Point imaging; Pulmonary lesions

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BENIGN TUMOR; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; LUNG INJURY; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PATIENT REFERRAL; PHYSICIAN; POSITRON EMISSION TOMOGRAPHY; SCINTILLATION CAMERA; SENSITIVITY ANALYSIS;

EID: 34547818228     PISSN: 02126982     EISSN: 1578200X     Source Type: Journal    
DOI: 10.1157/13107971     Document Type: Article

References (26)

1. Shulkin AN. Management of the indeterminate solitary pulmonary nodule: a cooperative study. Ann Thorac Surg. 1993;56:743-4.
2. Stoller JK, Ahmad M, Rice TW. Solitary pulmonary nodules. Cleve Clin J Med. 1988;55:68-71.
3. Odell MJ, Reid KR. Does percutaneous fine-needle aspiration biopsy aid in the diagnosis and surgical management of lung masses? Can J Surg. 1999;42:297-301.
4. Tsukada H, Satou T, Iwashima A, Souma T. Diagnostic accuracy of CT-guided automated needle biopsy of lung nodules. AJR Am J Roentgenol. 2000;175:239-43.
5. Dewan NA, Reeb SD, Gupta NC, Gobar LS, Scott WJ. PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis. Chest. 1995;108:441-6.
6. Kubota K, Matsuzawa T, Fujiwara T, Ito M, Hatazawa J, Ishiwata K, et al. Differential diagnosis of lung tumor with positron emission tomography: a prospective study. J Nucl Med. 1990;31: 1927-32.
7. Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA. 2001;285:914-24.
8. Koturo H, Yoshimichi U, Hiroyasu S, et al. Fluorine-18-FDG PET imaging is negative in bronchioalveolar carcinoma. J Nucl Med. 1998;39:1016-20.
9. Hustinx R, Smith RJ, Benard F, Rosenthal DI, Machtay M, Farber LA, et al. Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in head and neck. Eur J Nucl Med. 1999;26:1345-8.
10. Conrad GR, Sinha P. Narrow time window dual-point 18F-FDG PET for the diagnosis of thoracic malignancy. Nucl Med Commun. 2003;24:1129-37.
11. Matthies A, Kickeson M, Cuchiara A, Alavi A. Dual time point 18F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med. 2002;43:871-5.
12. Zhuang H, Pourdehnad M, Lambright ES, Yamamoto AJ, Lanuti M, Li P, et al. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med. 2001;42:1412-7.
13. Demura Y, Tsuchida T, Ishizaki T, Mizuno S, Totani Y, Ameshina S, et al. 18F-FDG Accumulation with PET for differentiation between benign and malignant lesions in the thorax. J Nucl Med. 2003;44:540-8.
14. Boerner AR, Weckesser M, Herzog H, Schmitz T, Audretsch W, Nitz U, et al. Optimal scan time for fluorine-18 fluorodeoxiglucose positron emission tomography in breast cancer. Eur J Nucl Med. 1999;26:226-30.
15. Ziegler SI, Enterrotacher A, Boning G, Schwaiger M. Performance characteristics of a dual head coincidence camera for the detection of small lesions [abstract]. J Nucl Med. 1997;38:206.
16. Lowe VJ, Fletcher JW, Gobar L, Lawson M, Kirchner P, Valk P, et al. Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol. 1998;16:1075-84.
17. Gupta NC, Maloof J, Gunel E. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. J Nucl Med. 1996;37:943-8.
18. Patz EF Jr, Lowe VJ, Hoffman JM, Paine SS, Burrowes P, Coleman RE, et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology. 1993;188: 487-90.
19. Ho Shon I, O'Doherty MJ, Maisey MN. Positron emission tomography in lung cancer. Semin Nucl Med. 2003;32:240-71.
20. Hamberg LM, Hunter GJ, Alpert NM, Choi NC, Babich JW, Fischman AJ. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? J Nucl Med. 1994;35:1308-12.
21. Bakheet SM, Powe J. Benign causes of 18-FDG uptake on whole body imaging. Semin Nucl Med. 1998;28:352-8.
22. Gupta NC, Frank AR, Dewan NA, Redepenning LS, Rothberg ML, Mailliard JA, et al. Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology. 1992;184:441-4.
23. Higashi K, Ueda Y, Sakuma T, Seki H, Oguchi M, Taniguchi M, et al. Comparison of [(18)F] FDG PET and (201) Tl SPECT in evaluation of pulmonary nodules. J Nucl Med. 2001;42:1489-96.
24. Inoue T, Kim EE, Wong FC, Yang DJ, Bassa P, Wong WH, et al. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors. J Nucl Med. 1996;37:1472-6.
25. Inoue T, Koyama K, Oriuchi N, Alyafei S, Yuan Z, Suzuki H, et al. Detection of malignant tumors: whole-body PET with fluorine 18 alpha-methyl tyrosine versus FDG. Preliminary study. Radiology. 2001;220:54-62.
26. Imdahl A, Nitzsche E, Krautmann F, Hogerle S, Boos S, Einert A, et al. Evaluation of positron emission tomography with 2-[F-18]-fluoro-2-deoxy-D- glucose for the differentiation of chronic pancreatitis and pancreatic cancer. Br J Surg. 1999;86:194-9.